Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
492,937,031
-
Number of holders
-
461
-
Total 13F shares, excl. options
-
475,123,500
-
Shares change
-
+8,274,832
-
Total reported value, excl. options
-
$13,465,426,403
-
Value change
-
+$218,382,206
-
Put/Call ratio
-
2.06%
-
Number of buys
-
225
-
Number of sells
-
-194
-
Price
-
$28.38
Significant Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN) as of Q4 2021
542 filings reported holding ELAN - Elanco Animal Health Inc - COMMON STOCK as of Q4 2021.
Elanco Animal Health Inc - COMMON STOCK (ELAN) has 461 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 475,123,500 shares
of 492,937,031 outstanding shares and own 96.39% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (40,801,815 shares), PRICE T ROWE ASSOCIATES INC /MD/ (34,465,054 shares), PRIMECAP MANAGEMENT CO/CA/ (30,158,966 shares), Aristotle Capital Management, LLC (29,210,842 shares), Sachem Head Capital Management LP (27,835,500 shares), BlackRock Inc. (24,586,865 shares), Dodge & Cox (22,218,300 shares), WELLINGTON MANAGEMENT GROUP LLP (19,860,257 shares), AMUNDI (14,808,161 shares), and STATE STREET CORP (12,576,000 shares).
This table shows the top 461 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.